<?xml version='1.0' encoding='UTF-8'?>
<DOC><DOCNO>WSJ900518-0001</DOCNO><DOCID>900518-0001.</DOCID><HL>   SEC's Investigation   Of Baxter Focusing   On Bribery Charges</HL><DATE>05/18/90</DATE><SO>WALL STREET JOURNAL (J), PAGE A12</SO><CO>   BAX MDEST</CO><IN>MEDICAL SUPPLIES (MDS)</IN><GV>COMMERCE DEPARTMENT (COM)SECURITIES AND EXCHANGE COMMISSION (SEC)</GV><LP>   WASHINGTON -- A Securities and Exchange Commission inquiryinto Baxter International Inc.'s Mideast activities isfocusing on possible violations of federal anti-bribery laws.   Investigators are seeking to determine whether theDeerfield, Ill., hospital supplier violated the ForeignCorrupt Practices Act in its efforts to win access to SaudiArabia and other Arab markets, say individuals familiar withthe staff inquiry. The law prohibits payments to foreignofficials by U.S. firms eager to gain business overseas.</LP><TEXT>   G. Marshall Abbey, Baxter's senior vice president andgeneral counsel, said, &quot;We have and still do emphaticallydeny that there was any improper payment made&quot; by Baxterofficials in the Middle East.   Both the SEC and the Commerce Department are looking intoevents surrounding Baxter's 1989 removal from the ArabLeague's blacklist of corporations that do business withIsrael. The SEC inquiry also involves Baxter's Middle Easternactivities during the mid-1980s, when the blacklistingfrustrated the company's efforts to enter the Mideast market.Baxter's activities in the Middle East and the government'sinquiry were the subject of a May 1 article in The WallStreet Journal.   Specific matters under SEC scrutiny include allegationsraised in 1985 civil litigation in federal court in New York.In that case, a former Baxter executive charged companyofficials with making improper payments to Saudi officialsand businessmen by cutting prices on products sold to a Saudigovernment contractor. Baxter denied the charges by theexecutive and made counter-allegations against him. He alsodenied the charges. The case was settled and sealed withneither side admitting guilt.   The SEC inquiry hasn't been expanded into a formalinvestigation.</TEXT></DOC>